Home Tags Osagie Ehanire

Tag: Osagie Ehanire

Health

Over one billion people worldwide are living with hypertension – Health...

newsheadline247 -
Osagie Ehanire - newsheadline247.com
Health

$29 million spent on 40 million COVID-19 vaccines for Nigerians –...

newsheadline247 -
NAFDAC: AstraZeneca COVID-19 vaccine approved for use in Nigeria - newsheadline247.com
Coronavirus Updates

NAFDAC: AstraZeneca COVID-19 vaccine approved for use in Nigeria

newsheadline247 -
Why resident doctors suspended nationwide strike – Official - newsheadline247.com
Health

FG replaces striking doctors with NYSC members…says industrial action ill-timed

newsheadline247 -
Nigeria will benefit from 2bn COVID-19 vaccine doses for poorer countries, says health minister - newsheadline247.com
Coronavirus Updates

Nigeria will benefit from 2 billion COVID-19 vaccine doses for poorer...

newsheadline247 -
Osagie Ehanire - newsheadline247.com
Coronavirus Updates

There could be regrets if we don’t comply with COVID-19 safety...

newsheadline247 -
WHO suspends trial of hydroxychloroquine as COVID-19 treatment - newsheadline247.com
Coronavirus Updates

COVID-19: Nigeria seeks India collaboration on production of vaccine

newsheadline247 -
Osagie Ehanire - newsheadline247.com
Coronavirus Updates

COVID-19: Brace up for virus surge, minister alerts Nigerians

newsheadline247 -
Osagie Ehanire/newsheadline247.com
Coronavirus Updates

Coronavirus: Nigeria to begin trial of COVID-19 ‘life-saving’ drug Dexamethasone –...

newsheadline247 -
Osagie Ehanire - newsheadline247.com
Health

COVID-19: Health Minister charges Pharmacists Council on level of sufficiency in...

newsheadline247 -
12Page 1 of 2

EDITOR PICKS

OPINION

POPULAR CATEGORY

ABOUT US

newsheadline247.com is a complete independent medium with allegiance for the truth regardless who is involved. With powerful online presence, newsheadline247.com is noted for its core values – Excellence, Integrity, Professionalism and Creativity

Contact us: newsheadline247@gmail.com +234 (0)8023211536

FOLLOW US